With the release of its pediatric COVID-19 vaccine, Pfizer switched the buffer used in its formulation to increase the stability of the product, allowing it to remain at refrigerator temperatures for longer. The Food and Drug Administration OK'd the ...
from Google Alert - health https://ift.tt/3nzdvJa
via IFTTT
0 comments:
Post a Comment